REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioanalisis Farmaceuticos S.A.S. (Colombia)

Main Activities: Scientific Research and Development Services
Full name: Bioanalisis Farmaceuticos S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioanalisis Farmaceuticos S.A.S. is a company in Colombia, with a head office in Bogota D.C.. It operates in the Scientific Research and Development Services industry. It was incorporated on August 22, 2006. The total number of employees is currently 36 (2024). From the latest financial highlights, Bioanalisis Farmaceuticos S.A.S. reported a net sales revenue increase of 17.02% in 2023. Its total assets grew by 8.41% over the same period. In 2023, Bioanalisis Farmaceuticos S.A.S.’s net profit margin increased by 2.14%.

Headquarters
Carrera 15 # 56 - 11
Bogota D.C.; Bogota D.C; Postal Code: 0210

Contact Details: Purchase the Bioanalisis Farmaceuticos S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bioanalisis Farmaceuticos S.A.S. report to view the information.
Outstanding Shares:
Purchase the Bioanalisis Farmaceuticos S.A.S. report to view the information.
Incorporation Date:
August 22, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bioanalisis Farmaceuticos S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.02%
Total operating revenue
17.02%
Operating profit (EBIT)
74.24%
Net Profit (Loss) for the Period
42.34%
Total assets
8.41%
Total equity
35.27%
Operating Profit Margin (ROS)
7.61%
Net Profit Margin
2.14%
Return on Equity (ROE)
1.86%
Quick Ratio
0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?